Clinical trials are the lifeblood of drug development. No medicine can win approval without being proven safe and effective in volunteers.

But during the early months of the COVID-19 pandemic, most clinical research was derailed by shuttered clinics and hospitals that didn’t have time for anything but urgent care. Suddenly, virtual visits and in-home care – which had seemed impossible before – became routine.